Cargando…
Benzodiazepine use and risk of Alzheimer’s disease: case-control study
Objectives To investigate the relation between the risk of Alzheimer’s disease and exposure to benzodiazepines started at least five years before, considering both the dose-response relation and prodromes (anxiety, depression, insomnia) possibly linked with treatment. Design Case-control study. Sett...
Autores principales: | Billioti de Gage, Sophie, Moride, Yola, Ducruet, Thierry, Kurth, Tobias, Verdoux, Hélène, Tournier, Marie, Pariente, Antoine, Bégaud, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159609/ https://www.ncbi.nlm.nih.gov/pubmed/25208536 http://dx.doi.org/10.1136/bmj.g5205 |
Ejemplares similares
-
Benzodiazepine use and risk of dementia: prospective population based study
por: Billioti de Gage, Sophie, et al.
Publicado: (2012) -
Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database
por: Billioti de Gage, Sophie, et al.
Publicado: (2018) -
High daily doses of benzodiazepines among Quebec seniors: prevalence and correlates
por: Egan, Mary Y, et al.
Publicado: (2001) -
Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case–control study
por: Moride, Yola, et al.
Publicado: (2005) -
Impact of benzodiazepine consumption reduction on future burden of dementia
por: Jacqmin-Gadda, Hélène, et al.
Publicado: (2020)